Evidence: GLP-1 Medications and Cholesterol Semaglutide and Tirzepatide Earlier GLP-1s like semaglutide and dual agonists like tirzepatide already showed modest improvements in lipid profiles: LDL cholesterol reduction by 510% Triglyceride reduction by 1520% Mild HDL increase These effects were partly due to weight loss , but researchers suspected other mechanisms were at play
Ipamorelin The first selective growth hormone secretagogue that stimulates GH release without affecting ACTH, cortisol, or prolactin levels, investigated for bone health, muscle preservation, and gastrointestinal recovery
Expedited Refills : Quick refill processing means you wont miss a beat on your wellness path
In fact, 91% of trial participants maintained their weight loss through the full 48-week study without regain
For Canadian patients who choose the research peptide pathway, quality verification becomes critical
At 12 mg, nausea affected about 42%, vomiting 25%, diarrhoea 32% and constipation 26%